Cordis® EXOSEAL® Vascular Closure Device
FDA premarket approval P100013/S025 · decided 2023-02-13
Approval details
- PMA number
- P100013
- Supplement
- S025
- Supplement type
- Normal 180 Day Track No User Fee
- Supplement reason
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- Cordis® EXOSEAL® Vascular Closure Device
- Generic name
- Device, hemostasis, vascular
- Applicant
- Cordis US Corporation
- Date received
- 2022-09-15
- Decision date
- 2023-02-13
- Days to decision
- 151 days
- Decision code
- APPR
- Product code
- MGB
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Miami Lakes, FL
- Statement
- Approval for a manufacturing site named Nutek Bravo located at 26545 Corporate Ave, Hayward, CA 94545 USA for sterilization of the EXOSEAL device.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.